Articles of Association

§ 1 Name
The name of the Association is DANSK BIOTEK – with the alias Foreningen af Bioteknologiske Industrier i Danmark.

§ 2 Object
The object of the Association is to promote the conditions for biotechnological research, development and production in Denmark and safeguard the companies’ common interests regarding this nationally and internationally.

§ 3 Membership
Private companies in Denmark, who research, develop or produce drugs or other products based substantially on biotechnology (biotech companies) or their parent companies may be received as regular members.

Furthermore, investment funds that actively own biotech companies may be received as regular members.

Private companies and organisations that offer substantial advice or in other ways support biotech companies may be received as associated members.

Application for membership shall be presented to the board for approval.

§ 4 Resignation
A member may resign from the Association by written notice with a notice period of at least six months.

§ 5 General Meeting
The General Meeting is the upper authority of the Association.

The Annual General Meeting shall be held before the end of May each year.

The announcement of the Annual General Meeting is initiated by the Chairman by ordinary mail or e-mail at least 14 days in advance of the Annual General Meeting including the agenda.

Each regular member of the Association has one vote at the General Meeting.

§ 6 Agenda
The agenda for the Annual General Meeting includes as a minimum the following items:

a) Chairman’s Statement
b) Approval of financial result
c) Determination of membership fee
d) Election of Chairman
e) Election of Members of the Board
f) Election of an Auditor
g) Discussion of proposals
h) AOB.

Proposals from members to be discussed at the General Meeting shall be submitted to the Chairman at least 30 days in advance of the Annual General Meeting to be distributed with the announcement.

§ 7 Extraordinary General Meeting
An Extraordinary General Meeting is announced by the Chairman, initiated by the Board or upon request from at least three members. Announcement of an extraordinary general meeting shall take place at least 8 days in advance of the meeting and include the agenda.

Resumées from the general meetings shall be distributed to the members.

§ 8 The Board
The Board and the Chairman are elected for a two year period and may be re-elected.

The Board consists of 4 – 8 members, representing regular members. One or more observers may be attached to the Board.

None of the Board Members, incl. the Chairman, may represent the same Company or company related businesses.

§ 9 Management and Representation
The Association is managed and represented by the Board.

The Board organises the work and the mailing of material to the members, and initiates meetings for the members to an exstent considered necessary.

The Board may attach a secretary function to the Association.

§ 10 Accounts
The Financial year follows the annual calendar.

§ 11 The provisions regulating the power
The provisions regulating the power is bound by the Chairman together with one member of the Board or the full Board. The Board, individual Board members or the secretary may be assigned prokura.

§ 12 Termination
For termination of the Association, exclusion of a member as well as for changing the articles of association a majority of 3/4th of the members of the Association is mandatory.

If the General Meeting in such matters isn’t competent to transact business, the Chairman may call for an Extraordinary General Meeting. At the Extraordinary General Meeting the items, handled already may be adopted by 3/4th of the votes given at the Extraordinary General Meeting.

Approved at the General Meeting, 5th may, 2008.

If you can't find it here or have feedback to our website, please do not hesitate to contact me on kp@danskbiotek.dk or 28895854

Copyright 2016 Danskbiotek. All rights reserved.